Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Binding to Blood Components01:30

Drug Binding to Blood Components

249
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
249
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

302
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
302
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

13.4K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.4K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

931
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
931
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

253
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
253
Ligand Binding Sites02:40

Ligand Binding Sites

13.2K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetically Predicted 25-Hydroxyvitamin D Levels on Hypothyroidism: A Two-Sample Mendelian Randomization.

BioMed research international·2026
Same author

A bond-aware graph neural network integrated with docking, pharmacophore modeling and molecular dynamics for JAK2 inhibitors affinity prediction.

Biochimica et biophysica acta. Proteins and proteomics·2026
Same author

Machine learning-driven drug repurposing for GPR17: activity prediction via graph neural networks and multistage computational validation.

Journal of biomolecular structure & dynamics·2026
Same author

Influence of acid structure and acidity strength on thermochemical, in-situ nitrogen generation.

Scientific reports·2026
Same author

Molecular Dynamics Simulations Reveal Heavy Water-Induced Structural Changes in Subunit c of ATP Synthase and Formation of Aligned Clusters.

Current medicinal chemistry·2026
Same author

Within-family analysis of PRS<sub>313</sub>: insights into breast cancer risk prediction.

Journal, genetic engineering & biotechnology·2025

Related Experiment Video

Updated: Sep 10, 2025

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
08:34

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening

Published on: October 16, 2015

10.1K

Insights into cannabinoid-HSA interactions: spectroscopic analysis and molecular docking for binding site

Sogol Meknatkhah1, Mohammad Reza Ashrafi-Kooshk1, Hossein Lanjanian2

  • 1Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

Journal of Biomolecular Structure & Dynamics
|August 26, 2025
PubMed
Summary

Human serum albumin (HSA) binding influences cannabinoid pharmacokinetics. This study reveals hydrophobic interactions and specific binding sites, crucial for designing effective cannabinoid therapies.

Keywords:
Cannabinoidhuman serum albuminmolecular dockingspectroscopic analysis

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

523

Related Experiment Videos

Last Updated: Sep 10, 2025

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
08:34

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening

Published on: October 16, 2015

10.1K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

523

Area of Science:

  • Pharmacology
  • Biochemistry
  • Drug Delivery

Background:

  • Cannabinoids show therapeutic promise but their pharmacokinetics are unclear due to hydrophobicity and protein binding.
  • Human serum albumin (HSA) is a key carrier protein affecting lipophilic drug distribution and bioavailability.

Purpose of the Study:

  • To investigate the binding interactions between HSA and six major cannabinoids: THC, CBD, CBC, CBG, THCV, and CBDV.
  • To elucidate the molecular mechanisms and binding sites involved in these interactions.

Main Methods:

  • Fluorescence spectroscopy (including quenching and synchronous scanning)
  • Circular dichroism (CD) spectroscopy
  • Molecular docking simulations

Main Results:

  • Static quenching mechanism observed, indicating strong HSA-cannabinoid binding.
  • Hydrophobic forces primarily drive the interactions, confirmed by thermodynamic analysis.
  • Cannabinoids bind mainly to Sudlow's site I on HSA, interacting with hydrophobic residues.
  • Most cannabinoids minimally affect HSA's secondary structure, except for CBDV and CBG.

Conclusions:

  • Albumin plays a significant role in modulating cannabinoid pharmacokinetic profiles.
  • Understanding these binding interactions offers guidance for cannabinoid drug design and delivery.
  • This research provides molecular insights into cannabinoid transport and disposition.